The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Compugen Ltd(NASDAQ:CGEN) 
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody...
Website: http://www.cgen.com
Founded: 1981
Full Time Employees: 61
Sector: Healthcare
Industry: Biotechnology
Compugen Days Payable Outstanding ttm (DPO)
Compugen Days Receivable Outstanding ttm (DSO)
Compugen Days Inventory Outstanding ttm (DIO)
Compugen Op Cashflow Per Share ttm
Compugen Free Cashflow Per Share ttm
Compugen Cash Per Share ttm
Compugen P/S ratio ttm
Compugen (GAAP) P/E ratio ttm
Compugen P/B ratio ttm
No extra charts and metrics for this ticker.